GOLDMAN SACHS GROUP INC Artiva Biotherapeutics, Inc. Common Stock (ARTV) 13F holding

GOLDMAN SACHS GROUP INC reported 11,465 ARTV shares valued at $73.8M as of 2026-03-31 (CMN). Cached 13F row, not a live tape.

Not investment advice. Cached 13F row, not EDGAR XML.